Ignite Creation Date:
2024-05-06 @ 11:17 AM
Last Modification Date:
2024-10-26 @ 12:43 PM
Study NCT ID:
NCT03481998
Status:
COMPLETED
Last Update Posted:
2023-11-21
First Post:
2018-03-14
Brief Title:
A Study of SHR6390 in Combination With Letrozole or Anastrozole or Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast Cancer
Sponsor:
Jiangsu HengRui Medicine Co Ltd
Organization:
Jiangsu HengRui Medicine Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-03-22
Start Date Type:
ACTUAL
Primary Completion Date:
2022-07-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-07-30
Completion Date Type:
ACTUAL
First Submit Date:
2018-03-14
First Submit QC Date:
March 27 2018
Study First Post Date:
2018-03-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-19
Last Update Post Date:
2023-11-21
Last Update Post Date Type:
ACTUAL